Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

Clinical trial NCT00327223 · COMPLETED

Trial details

NCT number: NCT00327223
Sponsor: AmpliMed Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Metastasis

Start date: 2005-11-01
Primary completion: 2006-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.